Compare KYMR & GLBE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KYMR | GLBE |
|---|---|---|
| Founded | 2015 | 2013 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4B | 6.3B |
| IPO Year | 2020 | 2021 |
| Metric | KYMR | GLBE |
|---|---|---|
| Price | $72.35 | $36.53 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 24 | 13 |
| Target Price | ★ $105.96 | $49.46 |
| AVG Volume (30 Days) | 740.7K | ★ 994.4K |
| Earning Date | 02-26-2026 | 02-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.04 |
| Revenue | $43,735,000.00 | ★ $888,450,000.00 |
| Revenue This Year | $18.71 | $29.22 |
| Revenue Next Year | N/A | $24.19 |
| P/E Ratio | ★ N/A | $846.66 |
| Revenue Growth | N/A | ★ 31.57 |
| 52 Week Low | $19.45 | $26.64 |
| 52 Week High | $103.00 | $63.69 |
| Indicator | KYMR | GLBE |
|---|---|---|
| Relative Strength Index (RSI) | 47.75 | 40.05 |
| Support Level | $70.00 | $36.13 |
| Resistance Level | $72.86 | $39.00 |
| Average True Range (ATR) | 3.44 | 1.37 |
| MACD | 0.04 | -0.19 |
| Stochastic Oscillator | 57.69 | 13.58 |
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
Global E Online Ltd provides e-commerce solutions. The company offers a platform to enable and accelerate direct-to-consumer cross-border e-commerce. The platform was purpose-built for international shoppers to buy seamlessly online and for merchants to sell from and anywhere in the world. The company localizes the shopper experience to make international transactions as seamless as domestic ones. The platform increases the conversion of international traffic into sales by removing much of the complexity associated with international e-commerce. The company derives maximum revenue from the United States.